Companies in Genomics
There are 8,452 companies in Genomics which include Ancestry, Illumina, Guardant Health, 23andMe, Natera. 3,783 companies in Genomics are funded, with 1,922 having secured Series A funding. Till date, the sector has seen the creation of 20 Unicorns. United States has the most number of companies in Genomics (3,817), followed by China
(542), and then United Kingdom (528).
On average, the last 10 years have seen 233 new companies launched every year. Most number of Genomics startups have been founded by alumni from Stanford University, Massachusetts Institute of Technology and Harvard University.
Here is a List of top companies in Genomics
1. Ancestry
Ancestry is a provider of an online genealogy platform offering a host of services. It offers family history information, historical records, and other genealogical information. It enables users to create their family tree and helps them discover, preserve and share their family history. The company uses microarray-based autosomal DNA testing technology and an online family history resource to predict family connections and relatives. The company offers a subscription-based service. The company claims its online resource contains all relevant Federal Census records since 1790 (Archives).
Key facts about Ancestry
- Founded Year: 1996
- Location: Lehi (United States)
- Stage: Acquired
- Total Funding till date: $446M
- Investors: Spectrum Equity, AOL and 18 Others
- Latest Funding Round: Post IPO, Apr 2016, $*****
- Tracxn Score: 82/100 What is this?
- Competitors Rank: 1 of 134 Competitors
2. Illumina
Developer of technologies for analysis of genetic variation and function. The company provides laboratory instruments, kits, and reagents for research, drug development, and the development of molecular tests. The product categories include gene panel and array finder, microarray kits, clinical research, and IVD products.
Key facts about Illumina
- Founded Year: 1993
- Location: San Diego (United States)
- Stage: Public
- Total Funding till date: $28M
- Investors: Lombard Odier, State Farm and 32 Others
- Latest Funding Round: Grant (prize money), Jan 01, 2020, $*****
- Tracxn Score: 80/100 What is this?
- Competitors Rank: 1 of 623 Competitors
Developer of digital sequencing technology for cancer detection. The product Guardant360 offers real-time, biopsy-free tumor sequencing for the analysis and identification of tumor-associated treatment options. Also, it has developed analytical tools, including a tumor response map and a mobile-enabled physician portal.
Key facts about Guardant Health
- Founded Year: 2012
- Location: Redwood City (United States)
- Stage: Public
- Total Funding till date: $557M
- Investors: Orbimed, Lightspeed Venture Partners and 24 Others
- Latest Funding Round: Post IPO, Nov 05, 2025, $*****
- Tracxn Score: 80/100 What is this?
- Competitors Rank: 1 of 640 Competitors
4. 23andMe
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits. The platform provides a study regarding an individual's ancestry, genealogy, and inherited traits. The company also markets its data is categorized and searchable form to researchers and scientists.
Key facts about 23andMe
- Founded Year: 2006
- Location: Sunnyvale (United States)
- Stage: Acquired
- Total Funding till date: $944M
- Investors: GSK, Johnson & Johnson Innovation – JJDC and 32 Others
- Latest Funding Round: Post IPO, Nov 03, 2023, $*****
- Tracxn Score: 78/100 What is this?
- Competitors Rank: 2 of 63 Competitors
5. Natera
Developer of cell-free DNA testing for oncology, women’s health, and organ health. The test provided by the company inlcude Signatera– a residual disease test (MRD), Altera– tumor genomic profile, Empower– Hereditary cancer test, Prospera Kidney– transplant assessment, Panorama– Noninvasive prenatal testing (NIPT), Anora– Miscarriage Test, and more.
Key facts about Natera
- Founded Year: 2004
- Location: Redwood City (United States)
- Stage: Public
- Total Funding till date: $152M
- Investors: HRC Fertility, Lightspeed Venture Partners and 17 Others
- Latest Funding Round: Post IPO, Apr 13, 2020, $*****
- Tracxn Score: 77/100 What is this?
- Competitors Rank: 2 of 771 Competitors
